InMed Pharmaceuticals Inc. revenue breakdown overview

InMed Pharmaceuticals Inc. revenue for the last year amounted to 4.60 M USD, the most of which — 4.60 M USD — came from its highest performing source at the moment, BayMedica, the year earlier bringing 4.14 M USD. The greatest contribution to the revenue figure was made by Canada — last year it brought InMed Pharmaceuticals Inc. 4.60 M USD, and the year before that — 4.14 M USD.